Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Response: relationship between vitamin D and depression in multiple sclerosis.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Cognitive dysfunction in multiple sclerosis.
Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder.
Purkinje cell pathology and loss in multiple sclerosis cerebellum.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
The impact of multiple sclerosis on family members: a review of the literature.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
[Optic neuritis: diagnosis, treatment and clinical implications].
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Is the treatment of multiple sclerosis headed in the wrong direction?
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
Effects of vitamin d3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells.
Lower urinary tract symptoms of neurological origin in urological practice.
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
Alemtuzumab: The advantages and challenges of a novel therapy in MS.
Endovascular correction of cerebrovenous anomalies in Multiple Sclerosis: A retrospective review of an uncontrolled case series.
Neuromyelitis optica in a patient with pemphigus foliaceus.
Condition-specific preference-based measures: benefit or burden?

Pages